Titel: Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Among Patients Treated With Immune Checkpoint Inhibitors Compared to Other Antineoplastic Medications: A Nationwide Study
- DOI
- 10.1002/pds.70272
- Published
- 2025-11
- Container
- Pharmacoepidemiology and Drug Safety
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/pds.70272,
title = {Titel: Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Among Patients Treated With Immune Checkpoint Inhibitors Compared to Other Antineoplastic Medications: A Nationwide Study},
author = {Ida M. Heerfordt and Magnus Middelboe and Christian Kjer Heerfordt and Henrik Horwitz and Rasmus Huan Olsen},
year = {2025},
journal = {Pharmacoepidemiology and Drug Safety},
doi = {10.1002/pds.70272},
url = {https://doi.org/10.1002/pds.70272}
}RIS
TY - JOUR TI - Titel: Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Among Patients Treated With Immune Checkpoint Inhibitors Compared to Other Antineoplastic Medications: A Nationwide Study AU - Ida M. Heerfordt AU - Magnus Middelboe AU - Christian Kjer Heerfordt AU - Henrik Horwitz AU - Rasmus Huan Olsen PY - 2025 JO - Pharmacoepidemiology and Drug Safety DO - 10.1002/pds.70272 UR - https://doi.org/10.1002/pds.70272 ER -
APA
Heerfordt, I. M., Middelboe, M., Heerfordt, C. K., Horwitz, H., & Olsen, R. H. (2025). Titel: Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Among Patients Treated With Immune Checkpoint Inhibitors Compared to Other Antineoplastic Medications: A Nationwide Study. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70272
Source records
- crossref · retrieved 2026-09-25T16:57:09.319Z